Estrogenic activities of di-2-ethylhexyl phthalate

Abstract

Phthalate esters are widespread in the environment. They have been described as being one of the most abundant man-made environmental contaminants that may be adverse to human health. Particularly, di-2-ethylhexyl phthalate (DEHP) has been shown to cause reproductive and developmental toxicity and is suspected to be an endocrine disruptor. The primary objective of this study is to determine the estrogenic activity of DEHP. Estrogenic activities of DEHP were studied by in vitro assays of human breast cancer MCF-7 cell proliferation. Estrogen-dependent MCF-7 cells were grown in RPMI1640 medium containing 10% fetal bovine serum. Five days before the addition of the test compounds, the cells were washed by phosphate balanced solution (PBS), and the medium was substituted with a phenol red-free RPMI1640 medium containing 5% dextral charcoal-stripped Fetal Bovine Serum (FBS). Fresh medium was added to the respective test compounds and the control cell received only the vehicle (ethanol). The proliferation of MCF-7 cell was analyzed by the MTT assay, growth curves, mitotic index and colony forming efficiency. Compared with the ethanol control cells, the proliferation of tested cells treated with DEHP, like estradiol, was significantly enhanced and the activity of the cell proliferation reached the maximum at 1 × 10^-3 mol/L DEHP. The relative proliferative potency of DEHP was 0.000 001 with a relative proliferative effect of 97.32%. During the log phase, the mitotic index of the tested cells treated with DEHP and estradiol was significantly increased. The cell cloning efficiency was enhanced, which was treated by 10^-3 mol/L DEHP only for 48 hours. The results show a time-dependent and dose-dependent model. Di-2-ethylhexyl phthalate enhanced the proliferation of human breast cancer MCF-7 cells in vitro and might demonstrate an estrogenic activity.

References

1. U.S. Environmental Protection Agency.Special report on environmentalendocrine disruption: an effects assessment and analysis, EPA/630/R-96/012. 1997. 2. Bauer M J, Herrmann R . Estimation of the environmentalcontamination by phthalic acid esters leaching from household wasters. Sci Total Environ, 1997, 208(1–2): 49–57 3. Yuan S Y, Liu C, Liao C S, Chang B V . Occurrenceand microbial degradation of phthalate esters in Taiwan river sediments. Chemosphere, 2002, 49(10): 1295–1299. doi:10.1016/S0045‐6535(02)00495‐2 4. Marttinen S K, Kettunen R H, Rintala J A . Occurrence and removal of organic pollutants in sewagesand landfill leachates. Sci Total Environ, 2003, 301(1–3): 1–12. doi:10.1016/S0048‐9697(02)00302‐9 5. Petersen J H, Breindahl T . Plasticizers in total dietsamples, baby food and infant formulae. Food Addit Contam, 2000, 17(2): 133–141. doi:10.1080/026520300283487 6. Staples C A, Parkerton T F, Peterson D R . A risk assessment of selected phthalate esters in NorthAmerican and western European surface waters. Chemosphere, 2000, 40(8): 885–891. doi:10.1016/S0045‐6535(99)00315‐X 7. Foster P M, Mylchreest E, Gaido K W, Sar M . Effects ofphthalate esters on the developing reproductive tract of male rats. Hum Reprod Update, 2001, 7(3): 231–235. doi:10.1093/humupd/7.3.231 8. Sharpe R M . Hormones and Testis Development and the Possible Adverse Effectsof Environmental Chemicals. Toxicol Lett, 2001, 120(2): 221–232. doi:10.1016/S0378‐4274(01)00298‐3 9. Soto A M, Sonnenschein C, Chung K L, Fernandez M F, Olea N, Serrano F O . The E-SCREEN assay as a tool to identify estrogens: anupdate on estrogenic environmental pollutants. Environ Health Perspect, 1995, 103(Suppl 7): 113–122. doi:10.2307/3432519 10. Gutendorf B, Westendorf J . Comparison of an array ofin vitro assays for the assessment of the estrogenic potential ofnatural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology, 2001, 166(1–2): 79–89. doi:10.1016/S0300‐483X(01)00437‐1 11. Shen L J, Zhou Y F, Jin T J . Experimental study on the estrogen-like effect of cadmium. Huanjing Yu Zhiye Yixue, 2001, 18(2): 67–69 (in Chinese) 12. Okubo T, Suzuki T, Yokoyama Y, Kano K, Kano I . Estimation of estrogenic and anti-estrogenicactivities of some phthalate diesters and monoesters by MCF-7 cellproliferation assay in vitro. Biol Pharm Bull, 2003, 26(8): 1219–1224. doi:10.1248/bpb.26.1219 13. Jobling S, Reynolds T, White R, Parker M G, Sumpter J P . A variety of environmentally persistentchemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect, 1995, 103(6): 582–587. doi:10.2307/3432434 14. Harris C A, Henttu P, Parker M G, Sumpter J P . The estrogenic activity of phthalate esters in vitro. Environ Health Perspect, 1997, 105(8): 802–811. doi:10.2307/3433697 15. McLachlan J A . Environmental signaling: what embryos and evolution teach us aboutendocrine disrupting chemicals. EndocrRev, 2001, 22(3): 319–341. doi:10.1210/er.22.3.319 16. Colborn T, vom Saal F S, Soto A M . Developmental effects of endocrine-disrupting chemicalsin wildlife and humans. Environ HealthPerspect, 1993, 101(5): 378–384. doi:10.2307/3431890 17. Davis B J, Maronpot R R, Heindel J J . Di (2-ethylhexyl) phthalate suppresses estradiol andovulation in cycling rats. Toxicol ApplPharmacol, 1994, 128(2): 216–233. doi:10.1006/taap.1994.1200 18. Ishihara M, Itoh M, Miyamoto K, Suna S, Takeuchi Y, Takenaka I, Jitsunari F . Spermatogenic disturbanceinduced by di-(2-ethylhexyl) phthalate is significantly preventedby treatment with antioxidant vitamins in the rat. Int J Androl, 2000, 23(2): 85–94. doi:10.1046/j.1365‐2605.2000.00212.x 19. Lovekamp-Swan T, Davis B J . Mechanisms of phthalate estertoxicity in the female reproductive system. Environ Health Perspect, 2003, 111(2): 139–146 20. Lampen A, Zimnik S, Nau H . Teratogenic phthalate esters and metabolites activatethe nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol Appl Pharmacol, 2003, 188(1): 14–24. doi:10.1016/S0041‐008X(03)00014‐0 21. Gazouli M, Yao Z X, Boujrad N, Corton J C, Culty M, Papadopoulos V . Effectof peroxisome proliferation on Leyding cell peripheral-type benzodiazepinereceptor gene expression, hormone- stimulated cholesterol transport,and steroidogenesis: role of the peroxisome proliferation-activatorreceptor alpha. Endocrinology, 2002, 143(7): 2571–2581. doi:10.1210/en.143.7.2571 22. Nadal A, Ropero A B, Laribi O, Maillet M, Fuentes E, Soria B . Nongenomic actions of estrogens and xenoestrogens bybinding at a plasma membrane receptor unrelated to estrogen receptoralpha and estrogen receptor beta. ProcNatl Acad Sci USA, 2000, 97(21): 11603–11608. doi:10.1073/pnas.97.21.11603 23. Lauber S N, Ali S, Gooderham N J . The cooked food derived carcinogen 2-amino -1-methyl-6-phenylirnidazo[4, 5-b] pyridine is a potent oestrogen: a mechanistic basis for itstissue-specific carcinogenicity. Carcinogenesis, 2004, 2512(12): 2509–2517. doi:10.1093/carcin/bgh268 24. Mendez P, Azcoitia I, Garcia-Segura L M . Estrogen receptor [alpha] forms estrogen-dependentmultimolecular complexes with insulin-like growth factor receptorand phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol, 2003, 112: 170–176. doi:10.1016/S0169‐328X(03)00088‐3